Dr. Michael Ohh

Biography

Professor Michael Ohh received his PhD from the University of British Columbia and completed a postdoctoral fellowship at the MRC/NCIC under William G. Kaelin Jr. at the Dana-Farber Cancer Institute and Harvard Medical School. He is known for his pioneering work in cancer hypoxia biology, particularly regarding the fundamental mechanisms governing how cells adapt to changes in oxygen levels. His research has significantly contributed to the understanding of the molecular mechanisms that regulate tumor biology, especially the roles of the von Hippel-Lindau (VHL) tumor suppressor protein and RAS oncogenes in cancer development. Professor Ohh has published over 100 peer-reviewed articles in prestigious journals such as Nature Medicine, PNAS, and Science. He has received multiple accolades, including the Canadian Cancer Society’s Bernard Francine Dorval Prize and the Premier’s Research Excellence Award. Through his lab, Professor Ohh mentors graduate students and postdoctoral fellows, offering an interactive research environment enriched with state-of-the-art equipment. His research is at the intersection of molecular biology and protein biochemistry, aiming to elucidate the molecular basis of cancer-associated proteins and their role in oncogenesis.

Research Interests

Experience

Awards